Sarah B Ogle1, Lindel C Dewberry1, Todd M Jenkins2, Thomas H Inge1, Megan Kelsey1, Matias Bruzoni3, Janey S A Pratt4. 1. Children's Hospital Colorado and School of Medicine, University of Colorado, Aurora, Colorado. 2. Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and. 3. Lucile Packard Children's Hospital Stanford, Palo Alto, California. 4. Lucile Packard Children's Hospital Stanford, Palo Alto, California jsapratt@stanford.edu.
Abstract
OBJECTIVES: In this report, we compare weight loss, comorbidity resolution, nutritional abnormalities, and quality of life between younger and older adolescents after metabolic and bariatric surgery. METHODS: From March 2007 to December 2011, 242 adolescents (≤19 years of age) who underwent bariatric surgery at 5 clinical centers in the United States were enrolled in the prospective, multicenter, long-term outcome study Teen-Longitudinal Assessment of Bariatric Surgery. Outcome data from younger (13-15 years; n = 66) and older (16-19 years; n = 162) study participants were compared. Outcomes included percent BMI change, comorbidity outcomes (hypertension, dyslipidemia, and type 2 diabetes mellitus), nutritional abnormalities, and quality of life over 5 years post surgery. RESULTS: Baseline characteristics, except for age, between the 2 cohorts were similar. No significant differences in frequency of remission of hypertension (P = .84) or dyslipidemia (P = .74) were observed between age groups. Remission of type 2 diabetes mellitus was high in both groups, although statistically higher in older adolescents (relative risk 0.86; P = .046). Weight loss and quality of life were similar in the 2 age groups. Younger adolescents were less likely to develop elevated transferrin (prevalence ratio 0.52; P = .048) and low vitamin D levels (prevalence ratio 0.8; P = .034). CONCLUSIONS: The differences in outcome of metabolic and bariatric surgery between younger and older adolescents were few. These data suggest that younger adolescents with severe obesity should not be denied consideration for surgical therapy on the basis of age alone and that providers should consider adolescents of all ages for surgical therapy for obesity when clinically indicated.
OBJECTIVES: In this report, we compare weight loss, comorbidity resolution, nutritional abnormalities, and quality of life between younger and older adolescents after metabolic and bariatric surgery. METHODS: From March 2007 to December 2011, 242 adolescents (≤19 years of age) who underwent bariatric surgery at 5 clinical centers in the United States were enrolled in the prospective, multicenter, long-term outcome study Teen-Longitudinal Assessment of Bariatric Surgery. Outcome data from younger (13-15 years; n = 66) and older (16-19 years; n = 162) study participants were compared. Outcomes included percent BMI change, comorbidity outcomes (hypertension, dyslipidemia, and type 2 diabetes mellitus), nutritional abnormalities, and quality of life over 5 years post surgery. RESULTS: Baseline characteristics, except for age, between the 2 cohorts were similar. No significant differences in frequency of remission of hypertension (P = .84) or dyslipidemia (P = .74) were observed between age groups. Remission of type 2 diabetes mellitus was high in both groups, although statistically higher in older adolescents (relative risk 0.86; P = .046). Weight loss and quality of life were similar in the 2 age groups. Younger adolescents were less likely to develop elevated transferrin (prevalence ratio 0.52; P = .048) and low vitamin D levels (prevalence ratio 0.8; P = .034). CONCLUSIONS: The differences in outcome of metabolic and bariatric surgery between younger and older adolescents were few. These data suggest that younger adolescents with severe obesity should not be denied consideration for surgical therapy on the basis of age alone and that providers should consider adolescents of all ages for surgical therapy for obesity when clinically indicated.
Authors: Michael L Dansinger; Joi Augustin Gleason; John L Griffith; Harry P Selker; Ernst J Schaefer Journal: JAMA Date: 2005-01-05 Impact factor: 56.272
Authors: Cornelia L Griggs; Numa P Perez; Robert N Goldstone; Cassandra M Kelleher; David C Chang; Fatima Cody Stanford; Janey S Pratt Journal: JAMA Pediatr Date: 2018-12-01 Impact factor: 16.193
Authors: Payal Sawhney; Avani C Modi; Todd M Jenkins; Margaret H Zeller; Linda M Kollar; Thomas H Inge; Stavra A Xanthakos Journal: Surg Obes Relat Dis Date: 2013-05-03 Impact factor: 4.734
Authors: Thomas H Inge; Meg H Zeller; Todd M Jenkins; Michael Helmrath; Mary L Brandt; Marc P Michalsky; Carroll M Harmon; Anita Courcoulas; Mary Horlick; Stavra A Xanthakos; Larry Dolan; Mark Mitsnefes; Sean J Barnett; Ralph Buncher Journal: JAMA Pediatr Date: 2014-01 Impact factor: 16.193
Authors: Thomas H Inge; Todd M Jenkins; Stavra A Xanthakos; John B Dixon; Stephen R Daniels; Meg H Zeller; Michael A Helmrath Journal: Lancet Diabetes Endocrinol Date: 2017-01-06 Impact factor: 32.069
Authors: Giuseppina Imperatore; James P Boyle; Theodore J Thompson; Doug Case; Dana Dabelea; Richard F Hamman; Jean M Lawrence; Angela D Liese; Lenna L Liu; Elizabeth J Mayer-Davis; Beatriz L Rodriguez; Debra Standiford Journal: Diabetes Care Date: 2012-12 Impact factor: 19.112